Jessica Corbett is a senior editor and staff writer for Common Dreams.
The Federal Trade Commission on Friday initiated a legal process against middlemen that collectively administer about 80% of all prescriptions in the United States, accusing them of artificially inflating the list price of insulin drugs and blocking patients from accessing cheaper products. The FTC action targets the 'Big Three' pharmacy benefit managers : CVS Health's Caremark Rx, Cigna 's Express Scripts , and UnitedHealth Group's OptumRx.
Emma Freer, senior policy analyst for healthcare at the American Economic Liberties Project, pointed out that 'the FTC's case adds to the mounting, bipartisan criticism of the 'Big Three' PBMs, which for far too long have exploited their monopoly power to inflate drug prices and enrich shareholders at the expense of patients' health and pocketbooks.
Big Pharma Cigna Corporate Greed Cvs Federal Trade Commission Institute For Local Self-Reliance Insulin Pharmacy Benefit Managers Unitedhealth Group Healthcare
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Big Barda In Three Big Comics Books This Big Week From Big DC ComicsBig Barda, created by Jack Kirby for New Gods seems to be suddenly all over the DC Universe, like she's the new Batman or something.
Read more »
Big 12 Commissioner addresses possible addition of UConn: ‘Big brands, big markets, big fanbases matter’Big 12 Commissioner address possible addition of UConn: 'Big brands, big markets, big fanbases matter'
Read more »
FTC sues drug middlemen for allegedly inflating insulin pricesThe FTC suit targets the three biggest so-called pharmacy benefit managers, UnitedHealth Group’s Optum Rx, CVS Health’s Caremark and Cigna’s…
Read more »
FTC sues top three pharmacy middlemen over insulin pricesPolitical News and Conservative Analysis About Congress, the President, and the Federal Government
Read more »
FTC Sues Pharmacy Benefit Managers Over Inflated Insulin PricesThe Federal Trade Commission (FTC) has filed a lawsuit against three major pharmacy benefit managers (PBMs) – Optum Rx, Caremark, and Express Scripts – alleging that they artificially inflate insulin prices to boost profits.
Read more »
FTC sues pharmaceutical middlemen, claiming practices inflated insulin costYou'll find Jason fishing for smart interviews, digging for the heart of the story and spelling out how the news shapes what happens next.
Read more »